Evidence map›Paper›PMID 33477401›Full record

ReviewAntibiotics (Basel, Switzerland)2021

Clavulanic Acid Production by

Víctor A López-Agudelo, David Gómez-Ríos, Howard Ramirez-Malule

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genomic Diversity ofInternational journal of molecular sciences · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Environmental Factors Modulate the Role ofBioengineering (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Review
  19. Streptomyces clavuligerus: The Omics Era.Journal of industrial microbiology & biotechnology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Víctor A López-AgudeloEscuela de Ingeniería Química, Universidad del Valle, A.A., Cali 25360, Colombia.ORCID 0000-0003-1339-972X
David Gómez-RíosGrupo de Investigación en Simulación, Diseño, Control y Optimización de Procesos (SIDCOP), Departamento de Ingeniería Química, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín 050010, Colombia.ORCID 0000-0002-9858-9559
Howard Ramirez-MaluleEscuela de Ingeniería Química, Universidad del Valle, A.A., Cali 25360, Colombia.ORCID 0000-0003-1013-5809
Universidad del Valle · COUniversidad de Antioquia · CO

Funding

Ministerio de Ciencia Tecnología e Innovación (MinCiencias) Postdoctoral Fellowship 848-2019 approved with the project: "Desarrollo de un modelo metabólico cinético a escala del genoma que capture eventos de adaptación metabólica en Streptomyces clavuligerus".Universidad del Valle C.I. 21108
6 · The paper itself

Abstract

Clavulanic acid (CA) is an irreversible β-lactamase enzyme inhibitor with a weak antibacterial activity produced by

Indexed as

clavulanic aciddownstream processingstrain engineeringStreptomyces clavuligerussystems biology

Identifiers

PMID33477401
PMCPMC7830376
OpenAlexW3125661314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.